F. Hoffmann-La Roche Ltd: Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.
inc4225m
growX ventures’ Deeptech Bet: Building A Playbook For Patient Capital
Founded in 2008, growx aims to support around 20-24 startups over the next two and a half years with its second fund, half of which will be deployed in deeptech startups ...